PRESS RELEASE published on 04/30/2025 at 07:30, 1 year 4 months ago Nicox Provides Full Year 2024 Financial Results Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025 Financial Results Revenue Nicox NCX 470 VYZULTA
PRESS RELEASE published on 04/30/2025 at 07:30, 1 year 4 months ago Nicox : Résultats financiers de l’année 2024 Nicox annonce résultats financiers 2024, incluant CA de 7,9M€, produits exceptionnels de 13,7M€ et trésorerie de 10,5M€. Études cliniques NCX 470 en cours Résultats Financiers Trésorerie Études Cliniques Nicox NCX 470
BRIEF published on 03/19/2025 at 07:35, 1 year 5 months ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
BRIEF published on 03/19/2025 at 07:35, 1 year 5 months ago Nicox a terminé la dernière visite de l'essai de phase 3b NCX 470 sur le glaucome à Whistler Nicox Résultats Cliniques NCX 470 Glaucome Essai De Phase 3b
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 5 months ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 1 year 5 months ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
BRIEF published on 01/28/2025 at 07:35, 1 year 7 months ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 1 year 7 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 7 months ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 7 months ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
Published on 09/09/2026 at 00:35, 4 hours 7 minutes ago Troubadour Resources Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing
Published on 09/09/2026 at 00:25, 4 hours 17 minutes ago Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 5 hours 7 minutes ago The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 6 hours 12 minutes ago Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 6 hours 27 minutes ago GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Published on 09/08/2026 at 22:50, 5 hours 51 minutes ago Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 6 hours 36 minutes ago oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 10 hours 12 minutes ago Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago Damartex / Résultats de l'exercice 2025-2026
Published on 09/08/2026 at 11:00, 17 hours 42 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 17 hours 42 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
